Repression of EMT in cancer and fibrosis was regarded as the result of SIRT1-mediated inhibition of the TGF-β signaling pathway via Smad4 deacetylation, with consequent decreased MMP7 expression, E-cadherin degradation, and β-catenin nuclear translocation [73]. The gene discussed is TGFB1; the disease is cancer.